Allurion Technologies Holdings Inc. Held Annual Shareholder Meeting

Reuters2025-12-20
<a href="https://laohu8.com/S/ALUR">Allurion Technologies</a> Holdings Inc. Held Annual Shareholder Meeting

Allurion Technologies Holdings Inc. held its annual meeting of stockholders on December 18, 2025. Shareholders re-elected Omar Ishrak, M.D., Douglas Hudson, and R. Jason Richey to the Board of Directors. The appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2025 was ratified. An amendment and restatement of the 2023 Stock Option and Incentive Plan was approved, including an increase in authorized shares, an amended definition of Fully-Diluted Shares Outstanding, a lower non-employee director compensation limit, and an extension of the plan’s term. Shareholders also approved a reverse stock split of the company's common stock within a specified range. All proposals considered at the meeting were approved.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allurion Technologies Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-327032), on December 19, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment